CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings

Pediatric multiple sclerosis

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 58
Year: 2019
COI code: ISNRMED04_028
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Pediatric multiple sclerosis

  Afshin Fayyazi - Department of PediatricNeurology, Hamadan University Of Medical Sciences, Hamadan, Iran


Multiple Sclerosis (MS), a chronic inflammatory autoimmune disease of the central nervous system (CNS), is most commonly diagnosed in (young) adults, but can alsoaffect children. Pediatric MS, also referred to as pediatric-onset MS (POMS), earlyonset MS or juvenile MS, is generally defined as MS with an onset before the age of16 years (sometimes before the age of 18 years).Between 3 and 10% of patients with MS present under 16 years of age and < 1% less than 10 years of age. was 13.7years. The mean age at onset Pediatric MS has distinctive features and the disease course is different than adults.Children are less likely to develop primary or secondaryprogressive MS.98% of pediatric MS patients present with a relapsing–remitting course, compared with 84%of adult patients. Relapses appear to be more frequent in patients with POMS compared with adult onset MS .The clinical phenotype differs from that of adult patients.In that pediatric MS patients generally experience a more aggressive disease onset with a polyfocal presentation at disease onset and a higher relapse rate early in the disease course. „ Overall, children tend to have a more favorable outcome after a first clinical event. „ Secondary progression and disability milestones at ages approximately 10 years younger than patients with adult-onset disease, despite a slower development of irreversible disability.The 50% risks to reach expanded disability status Scale 3 and 6 were 23 and 28 years after MS onset, compared to 10 and 18 years in the comparator group. „ In pediatric MS time from onset to confirmed disability may be relatively long, but disability milestone is reached at an earlier age. „ MS is associated with significant cognitive impairment in childhood (31%). „ Children with initial clinically isolated syndrome(CIS) are more likely to develop MS than those with acute disseminated encephalomyelitis )ADEM) as initial diagnosis. „ Conversion from CIS to MS occurred in 38.8% of children and from ADEM to MS in 8.5% of children.„ The current first-line treatment of MS in children consists of either interferon beta or glatiramer acetate.


Perma Link
COI code: ISNRMED04_028

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Fayyazi, Afshin, 2019, Pediatric multiple sclerosis, the 4th avicenna congress of neuro rehabilitation(stroke,multiple sclerosis), همدان, دانشگاه علوم پزشكي و خدمات بهداشتي درماني همدان معاونت تحقيقات و فناوري, the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Fayyazi, Afshin, 2019)
Second and more: (Fayyazi, 2019)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)


The University/Research Center Information:
Type: Medical University
Paper No.: 2232
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper


COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.